As promised, the Office of the Director of National Intelligence (ODNI) last week formally withdrew a new rule on requesting declassification of classified ODNI records after receiving public complaints that it would have imposed onerous costs on requesters. A revised rule was then issued.
“ODNI received comments regarding the fee provisions [with] the recommendation that those provisions be withdrawn and replaced with fee provisions comparable to those in ODNI’s Freedom of Information Act program,” ODNI said in an April 22 Federal Register notice. (Comments to that effect from the Federation of American Scientists are here; comments submitted by Openthegovernment.org are here.)
“ODNI agrees and therefore is withdrawing its direct final rule.”
A revised rule with amended fee provisions was published in the Federal Register today.
Under the revised rule:
* photocopying charges would be 10 cents per page instead of 50 cents per page;
* fees would be waived whenever costs incurred were $10 or less;
* and the revised rule now allows for a public interest waiver of fees when “the disclosure is likely to contribute significantly to the public understanding of the operations or activities of the United States Government and is not primarily in the commercial interest of the requester.”
The absence of consistent voting privileges for patient representatives on Advisory Committees hinders representatives from providing an voice on behalf of the community they represent.
Grant funds research of AI’s impact on nuclear weapons, biosecurity, military autonomy, cybersecurity, and other global issues.
AdComm members note a lack of transparency in recruitment methods, insufficient training, and limited understanding of regulatory procedures.
Internal disagreements present a growing concern about FDA leadership overruling the expert opinions of scientific staff and proceeding with official approvals, thus undermining staff expertise, decreasing agency morale, and potentially diminishing public trust.